ConductScience.org, home

Paper28322702

Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.

Hiramatsu Y and 5 others. Emerg Infect Dis, 2017. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan. Papers, record 28322702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28322702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.
PubMed
Journal
Emerg Infect Dis
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2020-12-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hiramatsu YYukihiro
2Miyaji YYusuke
3Otsuka NNao
4Arakawa YYoshichika
5Shibayama KKeigo
6Kamachi KKazunari

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial Outer Membrane ProteinsMajor topic
Bordetella pertussisMajor topic
Gene Expression Regulation, BacterialMajor topic
Virulence Factors, BordetellaMajor topic
Evolution, Molecular
Genotype
Japan
Mutation

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119751581Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.Emerg Infect Dis2009https://conductscience.org/library/papers/19751581PubMed
225312274Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.Vaccine2014https://conductscience.org/library/papers/25312274PubMed
322348138Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.PLoS One2012https://conductscience.org/library/papers/22348138PubMed
41988935Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1988935PubMed
524256623Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.Clin Vaccine Immunol2014https://conductscience.org/library/papers/24256623PubMed
625166348Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.Euro Surveill2014https://conductscience.org/library/papers/25166348PubMed
724124606Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan.PLoS One2013https://conductscience.org/library/papers/24124606PubMed
824655754Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.Emerg Infect Dis2014https://conductscience.org/library/papers/24655754PubMed
919666155First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.Vaccine2009https://conductscience.org/library/papers/19666155PubMed
1025301209Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.Clin Infect Dis2015https://conductscience.org/library/papers/25301209PubMed
1123776625Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains.PLoS One2013https://conductscience.org/library/papers/23776625PubMed
1220883738Safe and effective booster immunization using DTaP in teenagers.Vaccine2010https://conductscience.org/library/papers/20883738PubMed
1322841154Population diversity among Bordetella pertussis isolates, United States, 1935-2009.Emerg Infect Dis2012https://conductscience.org/library/papers/22841154PubMed
1426432908Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.Vaccine2015https://conductscience.org/library/papers/26432908PubMed
1525527446Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.Eur J Clin Microbiol Infect Dis2015https://conductscience.org/library/papers/25527446PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42368399Laboratory diagnosis of pertussis: A survey on provincial public health laboratory methods.Can Commun Dis Rep2026https://conductscience.org/library/papers/42368399PubMed
41438608Comparing frequentist and Bayesian methods to identify drivers of pathogen strain invasion: A temporal case study of pertussis in the United States.Infect Dis Model2026https://conductscience.org/library/papers/41438608PubMed
40709171Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.Front Immunol2025https://conductscience.org/library/papers/40709171PubMed
40366145Vaccine antigen-based genotyping of Bordetella pertussis by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019.Microbiol Spectr2025https://conductscience.org/library/papers/40366145PubMed
39686838Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact.Hum Vaccin Immunother2024https://conductscience.org/library/papers/39686838PubMed
39447192Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia.Emerg Infect Dis2024https://conductscience.org/library/papers/39447192PubMed
36270447Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia.J Glob Antimicrob Resist2022https://conductscience.org/library/papers/36270447PubMed
36047634Bordetella pertussis and outer membrane vesicles.Pathog Glob Health2023https://conductscience.org/library/papers/36047634PubMed
36032328Can vaccines control bacterial virulence and pathogenicity? Bordetella pertussis: the advantage of fitness over virulence.Evol Med Public Health2022https://conductscience.org/library/papers/36032328PubMed
35543837Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.Eur J Clin Microbiol Infect Dis2022https://conductscience.org/library/papers/35543837PubMed
35447067Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.Emerg Infect Dis2022https://conductscience.org/library/papers/35447067PubMed
34533118Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018.Euro Surveill2021https://conductscience.org/library/papers/34533118PubMed
34132167Naturally circulating pertactin-deficient Bordetella pertussis strains induce distinct gene expression and inflammatory signatures in human dendritic cells.Emerg Microbes Infect2021https://conductscience.org/library/papers/34132167PubMed
34014152Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis.Emerg Infect Dis2021https://conductscience.org/library/papers/34014152PubMed
32983069Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains.Front Microbiol2020https://conductscience.org/library/papers/32983069PubMed
31333640Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.Front Immunol2019https://conductscience.org/library/papers/31333640PubMed
31107218Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.Emerg Infect Dis2019https://conductscience.org/library/papers/31107218PubMed
30782265Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.Euro Surveill2019https://conductscience.org/library/papers/30782265PubMed
30559199Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30559199PubMed
29771235Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.Microb Genom2018https://conductscience.org/library/papers/29771235PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28322702

GET https://conductscience.org/api/papers/v1/28322702/authors